{
  "buildId": "Yo9IMmF0_CwyTDcEFOxB9",
  "gssp": true,
  "isFallback": false,
  "page": "/calc/[...slug]",
  "props": {
    "__N_SSP": true,
    "pageProps": {
      "calc": {
        "before_use": "",
        "calc_type": "",
        "chief_complaint_en": [
          "Fatigue",
          "Headache",
          "Weight Loss/Gain"
        ],
        "cmeEndDate": null,
        "cmeLastReviewed": null,
        "cmeReleaseDate": null,
        "cme_status": "",
        "content": {
          "about": {
            "evidence_based_medicine_en": "<p><span id=\"docs-internal-guid-b17ae4bf-7fff-cb28-d1af-d0df411f4538\">Guidelines for IRAE for endocrine toxicity (diabetes mellitus) were developed by a multidisciplinary, multi-organizational panel of experts in medical oncology based on a systematic review of the medical literature.</p>",
            "formula_en": "<div dir=\"ltr\" align=\"left\">\n<table><colgroup><col /><col /></colgroup>\n<tbody>\n<tr>\n<td>\n<p dir=\"ltr\"><strong>Criteria</strong></p>\n</td>\n<td>\n<p dir=\"ltr\"><strong>Hyperglycemia grade</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">Asymptomatic or mild symptoms; fasting glucose value &gt;160 mg/dL (&gt;8.9 mmol/L); no evidence of ketosis or laboratory evidence of T1DM&nbsp;</p>\n</td>\n<td>\n<p dir=\"ltr\">G1</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">Moderate symptoms, able to perform ADLs, fasting glucose value &gt;160-250 mg/dL (&gt;8.9-13.9 mmol/L), ketosis or evidence of T1DM at any glucose level</p>\n</td>\n<td>\n<p dir=\"ltr\">G2</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">Severe symptoms, medically significant or life-threatening consequences, unable to perform ADLs; fasting glucose level &gt;250-500 mg/dL (&gt;13.9-27.8 mmol/L)&nbsp;</p>\n</td>\n<td>\n<p dir=\"ltr\">G3</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">Severe symptoms, medically significant or life-threatening consequences, unable to perform ADLs; fasting glucose level &gt;500 mg/dL (&gt;27.8 mmol/L)&nbsp;</p>\n</td>\n<td>\n<p dir=\"ltr\">G4</p>\n</td>\n</tr>\n</tbody>\n</table>\n</div>\n<p dir=\"ltr\">See Next Steps for details on management.</p>",
            "more_info_en": "",
            "references_list": {
              "Clinical Practice Guidelines": [],
              "Manufacturer Website": [],
              "Original/Primary Reference": [
                {
                  "href": "https://www.ncbi.nlm.nih.gov/pubmed/29442540 ",
                  "text": "Brahmer JR, Lacchetti C, Schneider BJ, et al. Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol. 2018;36(17):1714-1768."
                }
              ],
              "Other References": [],
              "Outcomes": [],
              "Validation": []
            }
          },
          "contributor": {
            "expert_name": [
              "Nazli Dizman, MD"
            ]
          },
          "creator": [
            {
              "approved": false,
              "name": "Dr. Julie R. Brahmer",
              "qa_en": ""
            }
          ],
          "how_to_use": {
            "pearls_pitfalls_en": "<p><span id=\"docs-internal-guid-ada9f6d9-7fff-9a39-c396-3b7dbd370cd4\"></p>\n<ul>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Immune checkpoint inhibitor (ICPi) related diabetes mellitus should be suspected in patients with laboratory evidence or signs and symptoms of new or worsening hyperglycemia while on treatment with immune checkpoint inhibitors.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">May occur at any time during immune checkpoint inhibitor treatment.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Type 2 diabetes mellitus is more frequent and presents with worsening glycemic control. Type 1 diabetes mellitus is rarely seen, frequently presents with diabetic ketoacidosis and could lead to life threatening consequences.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Distinguishing type 1 diabetes mellitus from type 2 diabetes mellitus is necessary.</p>\n</li>\n</ul>",
            "use_case_en": "<p><span id=\"docs-internal-guid-54e76422-7fff-66ab-c004-e9456b848f45\">Adult patients with signs and symptoms of new or worsening hyperglycemia that developed while on treatment with immune checkpoint inhibitors including agents against PD-1 (i.e., pembrolizumab, nivolumab), PD-L1 (i.e., atezolizumab, avelumab, durvalumab), or CTLA-4 (i.e., ipilimumab).</p>",
            "why_use_en": "<p><span id=\"docs-internal-guid-53bbc706-7fff-2e87-4862-8e64956901d9\">This tool aids in the decision to discontinue ICPi, further diagnostic work-up, and oral antidiabetic or insulin treatment initiation. </p>"
          },
          "next_steps": {
            "advice_en": "<p><span id=\"docs-internal-guid-3e97d633-7fff-56c9-42a6-2fe4f5942f06\"></p>\n<ul>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Monitor patients for hyperglycemia or other signs and symptoms of new or worsening diabetes mellitus, at baseline and with each treatment cycle during induction for 12 weeks, then every 3 to 6 weeks.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Consider a patient&rsquo;s medical background, exposure history, and risk factors for identification of diabetes mellitus type.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">If type 1 diabetes mellitus is suspected diagnostic work up should include anion gap and urine ketones etc. Anti&ndash;glutamic acid decarboxylase, anti&ndash;islet cell, or anti&ndash;insulin antibodies, insulin and C-peptide levels can assist in the diagnosis.</p>\n</li>\n</ul>",
            "critical_actions_en": "<p dir=\"ltr\">Distinguishing type 1 diabetes mellitus from type 2 diabetes mellitus is necessary.&nbsp;</p>\n<p dir=\"ltr\">New onset hyperglycemia in a patient without risk factors of type 2 diabetes mellitus should raise concern for type 1 diabetes mellitus.</p>\n<p><span id=\"docs-internal-guid-456f0251-7fff-f114-5987-b3050d363382\"></p>\n<p dir=\"ltr\">Insulin is the treatment of choice for any patient where the diagnosis is in question.</p>",
            "management_en": "<p dir=\"ltr\">For all patients where an IRAE diagnosis is being considered, it is always recommended to involve the specialist or team prescribing the immune checkpoint therapy.&nbsp;</p>\n<p dir=\"ltr\"><strong>Grade 1:</strong></p>\n<ol>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">May continue ICPi with close clinical follow-up and laboratory evaluation.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Consider oral medications for those with new-onset type 2 diabetes mellitus.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Screen for T1DM if appropriate (i.e. acute onset with prior normal values or clinical concern for ketosis).</p>\n</li>\n</ol>\n<p dir=\"ltr\"><strong>Grade 2:</strong></p>\n<ol>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">May hold ICPi until serum glucose is controlled.&nbsp;</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">For worsening control in type 2 diabetes mellitus, titrate oral therapy consider insulin.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Administer insulin for type 1 diabetes mellitus or for patients whose diagnosis in question.&nbsp;</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Obtain urgent endocrine (preferred) or internal medicine consultation for patients with type 1 diabetes mellitus.&nbsp;</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Admission for patients with type 1 diabetes mellitus if ketoacidosis signs are present.</p>\n</li>\n</ol>\n<p dir=\"ltr\"><strong>Grade 3-4:</strong></p>\n<p><span id=\"docs-internal-guid-3ab2c604-7fff-8df4-ff3e-070e349dc36f\"></p>\n<ol>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Hold ICPi until toxicity recovers to grade &le;1.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Obtain urgent endocrine consultation.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Initiate insulin therapy.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Admit if there is concern for developing diabetic ketoacidosis, if the patient is symptomatic, if the patient with new onset type 1 diabetes mellitus is unable to see endocrinology.</p>\n</li>\n</ol>"
          },
          "related_resources": {
            "guidelines": [],
            "interests": [],
            "mdcalc_rating": [],
            "partner_contact": [],
            "sdm_tool": [],
            "teaching": [],
            "videos": []
          },
          "reviewer": []
        },
        "disease_en": [
          "Diabetes Mellitus",
          "Hyperglycemia"
        ],
        "dosing": false,
        "equation_logic_text": "var calc_output = [];\n\nvar grading = parseFloat(grading);\nvar rec;\n\nswitch (grading) {\n  case 1:\n    rec = 'May continue ICPi with close follow-up; if new onset T2DM consider oral antidiabetics; screen for T1DM if suspected; see Next Steps for details';\n    break;\n  case 2:\n    rec = 'May hold ICPi until serum glucose is controlled; titrate oral therapy or add insulin if worsening of preexisting T2DM; initiate insulin if T1DM is diagnosed or suspected; consult endocrinology if T1DM; consider hospital admission if T1DM and DKA or immediate outpatient evaluation is not available; see Next Steps for details';\n    break;\n  case 3:\n    rec = 'Hold ICPi until pt recovers to Grade ≤1; consult endocrinology; initiate insulin; admit if the patient is symptomatic, DKA development is concerned, or endocrinology is unavailable for patient with T1DM; see Next Steps for details';\n    break;\n  case 4:\n    rec = 'Hold ICPi until pt recovers to Grade ≤1; consult endocrinology; initiate insulin; admit if the patient is symptomatic, DKA development is concerned, or endocrinology is unavailable for patient with T1DM; see Next Steps for details';\n}\n\n//results\ncalc_output.push({\n    name: 'mini',\n    value: 'G'+grading,\n    value_text: '',\n    message: 'Hyperglycemia grade'   \n});\ncalc_output.push({\n    name: 'Score',\n    value: 'G'+grading,\n    value_text: '',\n    message: 'Hyperglycemia grade'   \n});\ncalc_output.push({\n    name: 'risk1',\n    value: '', \n    value_text: '',\n    message: rec\n});\n",
        "favorite_id": 10377,
        "full_title_en": "Immune-Related Adverse Events for Endocrine Toxicities - Diabetes Mellitus",
        "input_schema": [
          {
            "conditionality": "",
            "default": null,
            "label_en": "Criteria",
            "name": "grading",
            "optional": false,
            "options": [
              {
                "label": "Asymptomatic or mild symptoms; fasting glucose value >160 mg/dL (>8.9 mmol/L); no evidence of ketosis or laboratory evidence of T1DM ",
                "value": 1
              },
              {
                "label": "Moderate symptoms, able to perform ADLs, fasting glucose value >160-250 mg/dL (>8.9-13.9 mmol/L), ketosis or evidence of T1DM at any glucose level",
                "value": 2
              },
              {
                "label": "Severe symptoms, medically significant or life-threatening consequences, unable to perform ADLs; fasting glucose level >250-500 mg/dL (>13.9-27.8 mmol/L) ",
                "value": 3
              },
              {
                "label": "Severe symptoms, medically significant or life-threatening consequences, unable to perform ADLs; fasting glucose level >500 mg/dL (>27.8 mmol/L) ",
                "value": 4
              }
            ],
            "show_points": false,
            "tips_en": "",
            "type": "radio"
          }
        ],
        "instructions_en": "<p><span id=\"docs-internal-guid-08a1bb22-7fff-3a1e-ff4d-b174ebcaf9d9\">Use in adult patients with signs and symptoms of new or worsening hyperglycemia that developed while on treatment with immune checkpoint inhibitors.</p>",
        "logs": [
          {
            "message": "fixed typo",
            "time": "2021-06-04T16:26:00.000Z",
            "user": "sang"
          },
          {
            "message": "edited content",
            "time": "2021-05-25T10:25:00.000Z",
            "user": "tiffany"
          },
          {
            "message": "edited inputs",
            "time": "2021-05-25T10:08:00.000Z",
            "user": "tiffany"
          },
          {
            "message": "edited content",
            "time": "2021-05-25T10:07:00.000Z",
            "user": "tiffany"
          },
          {
            "message": "edit title",
            "time": "2021-05-25T10:04:00.000Z",
            "user": "tiffany"
          },
          {
            "message": "edited results",
            "time": "2021-05-04T10:25:00.000Z",
            "user": "michael"
          },
          {
            "message": "edited content",
            "time": "2021-04-29T16:21:00.000Z",
            "user": "tiffany"
          },
          {
            "message": "edited content",
            "time": "2021-04-29T16:14:00.000Z",
            "user": "tiffany"
          },
          {
            "message": "edited content",
            "time": "2021-04-29T16:13:00.000Z",
            "user": "tiffany"
          },
          {
            "message": "edita",
            "time": "2021-04-27T00:45:00.000Z",
            "user": "lubaina"
          },
          {
            "message": "added input",
            "time": "2021-04-25T00:52:00.000Z",
            "user": "lubaina"
          },
          {
            "message": "added search terms",
            "time": "2021-04-02T13:51:00.000Z",
            "user": "tiffany"
          },
          {
            "message": "edited content",
            "time": "2021-04-01T22:58:00.000Z",
            "user": "tiffany"
          },
          {
            "message": "added creator",
            "time": "2021-04-01T22:57:00.000Z",
            "user": "tiffany"
          },
          {
            "message": "added content",
            "time": "2021-04-01T19:05:00.000Z",
            "user": "tiffany"
          },
          {
            "message": "added content",
            "time": "2021-04-01T19:03:00.000Z",
            "user": "tiffany"
          },
          {
            "message": "created new calc page",
            "time": "2021-04-01T18:24:00.000Z",
            "user": "tiffany"
          }
        ],
        "md5": "",
        "medium_description_en": "<p>Grades severity of hyperglycemia secondary to immune checkpoint inhibitor therapy.</p>",
        "purpose_en": [
          "Diagnosis",
          "Prognosis"
        ],
        "search_abbreviation_en": [
          "Immune Related Adverse Events, irae, hyperglycemia, immune checkpoint inhibitor therapy, ICPi therapy, ASCO guideline, ASCO, Diabetes Mellitus, diabetes"
        ],
        "search_id": "c-10377",
        "seo": {
          "keywords_en": "Immune Related Adverse Events, irae, hyperglycemia, immune checkpoint inhibitor therapy, ICPi therapy, ASCO guideline, ASCO",
          "meta_description_en": "The Immune-Related Adverse Events for Endocrine Toxicities - Diabetes Mellitus grades severity of hyperglycemia secondary to immune checkpoint inhibitor therapy."
        },
        "short_description_en": "Hyperglycemia severity (ICPi therapy).",
        "short_title_en": "IRAE for Endocrine Toxicities - Diabetes",
        "slug": "immune-related-adverse-events-endocrine-toxicities-diabetes-mellitus",
        "specialty_en": [
          "Allergy and Immunology",
          "Endocrinology",
          "Hospitalist Medicine",
          "Internal Medicine"
        ],
        "system_en": [
          "Endocrine and Metabolic"
        ]
      },
      "contributors": [
        {
          "contributors_page": false,
          "createdAt": "2021-12-22T21:20:30.365Z",
          "description": "",
          "firstName": "Nazli",
          "hasDisclosure": [],
          "img": "",
          "lastName": "Dizman",
          "name": "Nazli Dizman, MD",
          "publishedAt": "2021-11-17T15:11:30.452Z",
          "signedCOI": true,
          "status": null,
          "target": "",
          "updatedAt": "2021-11-17T15:11:35.298Z"
        }
      ],
      "creators": [
        {
          "about_en": "<p>Julie R. Brahmer, MSc, MD, is the co-director of the upper aerodigestive department at Johns Hopkins Medicine in Baltimore, MD. She is also a professor of oncology at Johns Hopkins Medicine. Dr. Brahmer’s primary research is focused on treatment of lung cancer and mesothelioma.</p>",
          "createdAt": "2021-12-23T18:03:17.779Z",
          "deceased": null,
          "firstName": "",
          "lastName": "",
          "name": "Dr. Julie R. Brahmer",
          "photo_en": "https://cdn-web-img.mdcalc.com/people/dr-julie-brahmer.png",
          "publishedAt": "2021-11-17T15:11:30.452Z",
          "pubmedLink": "https://www.ncbi.nlm.nih.gov/pubmed/?term=Brahmer+JR%5BAuthor%5D",
          "signedCOI": false,
          "updatedAt": "2021-11-17T15:11:35.298Z"
        }
      ],
      "envs": {
        "CANONICAL_URL_ROOT": "https://www.mdcalc.com",
        "RECAPTCHA_PUBLIC_KEY": "6Lcu1mMkAAAAAAwmSDO3I7JNaUo9YtZ3jnrzTP6a",
        "STRAPI_TAG": "WEB_PROD",
        "STRIPE_PUB_KEY": "pk_live_yYm2UzDzaudhFgqWcKbv9vH7"
      },
      "faqs": [
        {
          "cme_faq": {
            "answer": "<p>MDCalc&rsquo;s Continuing Medical Education (CME) service allows users to easily earn AMA PRA Category 1 CreditsTM through regular use of MDCalc. Simply put, on top of getting the best medical calculators in the world, your usage will help you achieve your annual CME requirements, including specialty CME, without any extra effort.</p>",
            "createdAt": "2022-12-16T16:39:54.990Z",
            "publishedAt": "2022-12-16T16:39:55.697Z",
            "question": "What is MDCalc CME?",
            "type": "Using",
            "updatedAt": "2023-01-04T22:52:48.348Z"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>Yes, in support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and MDCalc Ltd. Inc. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.</p>",
            "createdAt": "2022-12-16T16:40:11.179Z",
            "publishedAt": "2022-12-16T16:40:11.883Z",
            "question": "Is MDCalc CME accredited?",
            "type": "Using",
            "updatedAt": "2023-02-09T18:38:00.345Z"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>Only United States attending physicians, nurse practitioners, nurses, and physician assistants are eligible for our CME service.</p>",
            "createdAt": "2022-12-16T16:40:27.936Z",
            "publishedAt": "2022-12-16T16:40:28.851Z",
            "question": "Who can enroll and how?",
            "type": "Using",
            "updatedAt": "2023-01-04T22:53:12.659Z"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>We have over 275 CME-eligible calculators across various specialties. You can read the clinical content supporting any CME calculators to start earning. Once you have viewed all the supporting content for a calculator, you will have officially earned the credit amount (0.5 credits) and will be able to redeem a certificate. For now, only calc content in CME-eligible calcs is eligible for CME credits, however, we&rsquo;ll be expanding our CME service to include more of our content in the future.</p>",
            "createdAt": "2022-12-16T16:40:47.203Z",
            "publishedAt": "2022-12-16T16:40:47.882Z",
            "question": "What activities can I do to earn CME credits?",
            "type": "Using",
            "updatedAt": "2023-01-04T22:53:27.268Z"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>Simply use our search bar or visit our homepage to easily find CME-eligible calcs. You must be enrolled in our CME service to see which calcs are CME-eligible.</p>",
            "createdAt": "2022-12-16T16:40:57.420Z",
            "publishedAt": "2022-12-16T16:41:02.863Z",
            "question": "Where can I find calcs with which I can earn credits?",
            "type": "Using",
            "updatedAt": "2023-01-04T22:53:44.504Z"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>Once you&rsquo;ve enrolled in our CME service, you will have a personal CME Dashboard where you can view all of your earned credits. You can navigate to the dashboard by clicking the CME button in the header at the top of any page.</p>",
            "createdAt": "2022-12-16T16:41:11.874Z",
            "publishedAt": "2022-12-16T16:41:13.038Z",
            "question": "Where can I see which credits I’ve earned?",
            "type": "Using",
            "updatedAt": "2023-01-04T22:53:52.153Z"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>Go to your CME Dashboard and select the credits you&rsquo;d like to redeem, fill out a few dropdown answers about how you used the calc, and then proceed to checkout.</p>",
            "createdAt": "2022-12-16T16:41:33.940Z",
            "publishedAt": "2022-12-16T16:41:35.646Z",
            "question": "How do I redeem CME credits?",
            "type": "Using",
            "updatedAt": "2023-01-04T22:54:07.237Z"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>No. Earning credits as you use calcs is free, but either you (or your employer) will need to purchase an annual subscription to redeem your CME certificates.</p>",
            "createdAt": "2022-12-16T16:41:59.307Z",
            "publishedAt": "2022-12-16T16:42:00.078Z",
            "question": "Are CME credits free?",
            "type": "Using",
            "updatedAt": "2023-01-04T22:54:22.467Z"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>Just like with earned credits, you can view your CME certificates on your CME Dashboard in the &ldquo;CME Certificates&rdquo; tab. Certificates include a list of all of the calcs for which CME was earned along with a tally of the specialty CME.</p>",
            "createdAt": "2022-12-16T16:42:10.712Z",
            "publishedAt": "2022-12-16T16:42:15.215Z",
            "question": "Where can I see my CME certificates?",
            "type": "Using",
            "updatedAt": "2023-01-04T22:54:32.826Z"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>One year from the date of purchase.</p>",
            "createdAt": "2022-12-16T16:42:52.839Z",
            "publishedAt": "2022-12-16T16:42:53.641Z",
            "question": "How long do credits in an annual subscription last?",
            "type": "Purchasing",
            "updatedAt": "2023-01-04T22:54:51.655Z"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>General; Addiction and Controlled Substances; Cardiac Care; Domestic and Intimate Partner Violence; Geriatrics; HIV and Infectious Disease; Hospice, End-of-Life, Terminal Illness, and Palliative Care; Mental and Behavioral Health; Pain Management; Pediatrics; Stroke; and Trauma.</p>",
            "createdAt": "2022-12-16T16:32:44.987Z",
            "publishedAt": "2022-12-16T16:32:46.006Z",
            "question": "What specialty CME credits are included in the plan?",
            "type": "Purchasing",
            "updatedAt": "2023-01-04T22:50:33.794Z"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>Your gift card will be sent via email within 1-2 business days of making your purchase. You will be able to select from the following options - Visa, Amazon.com, Apple. Be sure to claim your gift card offer within 90 days of receiving the email.</p>\n<p>Your CME purchase may have implications for tax reporting purposes. The cost of your CME product may or may not be tax-deductible when used for professional purposes. Any reimbursed amount for incentives must be declared as personal income for tax purposes. Please consult your tax advisor. MDCalc does not provide tax advice.</p>",
            "createdAt": "2022-12-16T16:33:18.512Z",
            "publishedAt": "2022-12-16T16:33:19.250Z",
            "question": "I ordered a CME package with a gift card. How does it work?",
            "type": "Purchasing",
            "updatedAt": "2023-01-04T22:50:53.878Z"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>Per the new guidelines from ACCME, the receipt will separate the cost you paid into the cost of the gift card and the cost of the CME learning activity.</p>",
            "createdAt": "2022-12-16T16:44:06.809Z",
            "publishedAt": "2022-12-16T16:44:07.518Z",
            "question": "What will show on my receipt for CME when it includes a gift card?",
            "type": "Purchasing",
            "updatedAt": "2023-01-04T22:55:08.549Z"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>You can get a refund (minus any promotional gift amount) within 30-days if the ease of earning and redeeming does not meet your expectations and if you have redeemed no more than 4 credits. Please email <a href=\"mailto:team@mdcalc.com\" target=\"_blank\" rel=\"noopener\">team@mdcalc.com</a> to request a refund.</p>",
            "createdAt": "2022-12-16T16:36:44.877Z",
            "publishedAt": "2022-12-16T16:36:45.950Z",
            "question": "How do I get a refund if I'm not satisfied?",
            "type": "Purchasing",
            "updatedAt": "2023-01-04T22:51:01.761Z"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>You can upgrade your subscription throughout your billing cycle and pay the difference for a higher plan. You may request to downgrade your plan to a lower level to coincide with your next renewal. Please email <a href=\"mailto:team@mdcalc.com\" target=\"_blank\" rel=\"noopener\">team@mdcalc.com</a> to request changes.</p>",
            "createdAt": "2022-12-16T16:37:26.433Z",
            "publishedAt": "2022-12-16T16:37:27.177Z",
            "question": "How do I later upgrade to a different plan if I need more credits?",
            "type": "Purchasing",
            "updatedAt": "2023-01-04T22:51:27.457Z"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>Gift card plans are available for 1 year and do not auto-renew. Standard, non gift-card subscriptions are auto-renewed annually. You can disable the automatic renewal of your subscription at any time by emailing <a href=\"mailto:team@mdcalc.com\" target=\"_blank\" rel=\"noopener\">team@mdcalc.com</a>.</p>",
            "createdAt": "2022-12-16T16:44:53.580Z",
            "publishedAt": "2022-12-16T16:44:56.993Z",
            "question": "Do CME plans auto-renew?",
            "type": "Purchasing",
            "updatedAt": "2023-01-04T22:55:44.653Z"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>If you&rsquo;re part of a team or practice that wants to sign up five or more physicians, please email us at <a href=\"mailto:team@mdcalc.com\" target=\"_blank\" rel=\"noopener\">team@mdcalc.com</a> for more information.</p>",
            "createdAt": "2022-12-16T16:38:26.466Z",
            "publishedAt": "2022-12-16T16:38:27.163Z",
            "question": "How do I get information on a discounted bulk subscription program for my institution, team, or practice?",
            "type": "Purchasing",
            "updatedAt": "2023-01-04T22:51:43.762Z"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>On July 28, 2022, ACCME updated the guidelines regarding the use of high-value incentives. These guidelines allow for the use of gift card rewards in a regulated manner. Visit the ACCME website to read their guidelines.</p>",
            "createdAt": "2022-12-16T16:46:21.538Z",
            "publishedAt": "2022-12-16T16:46:27.759Z",
            "question": "Did the ACCME decide to regulate gift cards?",
            "type": "Purchasing",
            "updatedAt": "2023-01-04T22:56:05.573Z"
          }
        }
      ],
      "headConfig": {
        "canonicalUrl": "/calc/10377/immune-related-adverse-events-endocrine-toxicities-diabetes-mellitus",
        "description": "The Immune-Related Adverse Events for Endocrine Toxicities - Diabetes Mellitus grades severity of hyperglycemia secondary to immune checkpoint inhibitor therapy.",
        "keywords": "Immune Related Adverse Events, irae, hyperglycemia, immune checkpoint inhibitor therapy, ICPi therapy, ASCO guideline, ASCO",
        "title": "Immune-Related Adverse Events for Endocrine Toxicities - Diabetes Mellitus"
      },
      "isCMECalc": false,
      "measurements": [],
      "relCalcs": [
        {
          "calcId": 10382,
          "short_title_en": "IRAE for Endocrine Toxicities - Hypothyroidism",
          "slug": "immune-related-adverse-events-endocrine-toxicities-hypothyroidism"
        },
        {
          "calcId": 10383,
          "short_title_en": "IRAE for Lung Toxicity - Pneumonitis",
          "slug": "immune-related-adverse-events-lung-toxicity-pneumonitis"
        },
        {
          "calcId": 10378,
          "short_title_en": "IRAE for Renal Toxicities - Nephritis",
          "slug": "immune-related-adverse-events-renal-toxicities-nephritis"
        }
      ],
      "societies": {
        "American Association for the Study of Liver Diseases": {
          "abbreviation": "AASLD",
          "description": "plain-text",
          "img": "https://s3-us-west-2.amazonaws.com/cdn-web-img.mdcalc.com/logo/other_society.png",
          "web_link": "https://www.aasld.org/"
        },
        "American College Of Emergency Physicians": {
          "abbreviation": "ACEP",
          "description": "plain-text",
          "img": "https://s3-us-west-2.amazonaws.com/apps.mdcalc.com/images/american-college-of-emergency-physicians-squarelogo.png",
          "web_link": "https://www.acep.org/"
        },
        "American College of Gastroenterology": {
          "abbreviation": "ACG",
          "description": "plain-text",
          "img": "https://s3-us-west-2.amazonaws.com/cdn-web-img.mdcalc.com/logo/acg_logo.png",
          "web_link": "https://gi.org/"
        },
        "American College of Rheumatology": {
          "abbreviation": "ACR",
          "description": "plain-text",
          "img": "https://s3-us-west-2.amazonaws.com/cdn-web-img.mdcalc.com/logo/other_society.png",
          "web_link": "https://www.rheumatology.org/"
        },
        "American Gastroenterological Association": {
          "abbreviation": "AGA",
          "description": "plain-text",
          "img": "https://apps.mdcalc.com/images/societies/aga.jpeg",
          "web_link": "https://gastro.org"
        },
        "American Heart Association": {
          "abbreviation": "AHA",
          "description": "plain-text",
          "img": "https://s3-us-west-2.amazonaws.com/apps.mdcalc.com/images/societies/+AHA+(American+Heart+Association).png",
          "target": "aha",
          "web_link": "http://www.heart.org/HEARTORG/"
        },
        "American Urological Association": {
          "abbreviation": "AUA",
          "description": "plain-text",
          "img": "https://s3-us-west-2.amazonaws.com/cdn-web-img.mdcalc.com/logo/other_society.png",
          "web_link": "https://www.auanet.org/"
        },
        "EB Medicine": {
          "abbreviation": "EB Medicine",
          "description": "EB Medicine is the premier provider of evidence-based clinical content and CME resources for emergency medicine practitioners.",
          "img": "https://cdn-web-img.mdcalc.com/other/eb_medicine-icon-only.jpg",
          "target": "eb-medicine",
          "web_link": "http://www.ebmedicine.net/"
        },
        "MDCalc CME": {
          "abbreviation": "MDCalc CME",
          "img": "https://cdn-web-img.mdcalc.com/Stroke-CME-content.jpg",
          "web_link": "https://www.mdcalc.com/stroke-cme?utm_source=NIHSS_calc&utm_medium=NIHSS_calc&utm_campaign=NIHSS_calc"
        },
        "OTHER": {
          "abbreviation": "OTHER"
        },
        "Postgraduate Institute for Medicine": {
          "abbreviation": "PIM",
          "description": "plain-text",
          "img": "https://cdn-web-img.mdcalc.com/PIM-circle-COLOR.jpeg",
          "target": "pim",
          "web_link": "https://www.pimed.com/"
        },
        "VACO Podcast": {
          "description": "Listen to the VACO co-creators break down how to use VACO\\, what it does\\, and what it doesn’t.",
          "img": "https://cdn-web-img.mdcalc.com/content/podcast 2.png",
          "web_link": "https://www.stimuluspodcast.com/post/32-the-covid-mortality-score-vaco"
        }
      },
      "validSections": [
        "whenToUseViewed",
        "pearlsPitfallsViewed",
        "whyUseViewed",
        "nextStepsViewed",
        "evidenceViewed"
      ]
    }
  },
  "query": {
    "slug": [
      "10377",
      "immune-related-adverse-events-endocrine-toxicities-diabetes-mellitus"
    ]
  },
  "scriptLoader": []
}